# 10 Facts you didn&#8217;t know about THC

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/10-facts-you-didnt-know-about-thc/
> **Published:** 2026-07-17T12:24:42-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:48:55-04:00
> **Clinical Summary:** How the endocannabinoid system mediates THC effects. CB1/CB2 physiology, genetic variation, and clinical dosing insights for physicians.

---

✦ New

CED Clinical Relevance
#67
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.

THCResearchNeurologySafetyMental HealthDosingIndustry

Dr. Caplan’s Take
“While the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) is a legitimate area of neuroscience research, many of the ‘facts’ circulating online about THC lack the human clinical evidence needed to guide [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), so I encourage people to distinguish between what we know from controlled studies versus what remains fascinating but preliminary neurobiology.”

Clinical Perspective

💊 While educational content about THC’s mechanisms, including its interaction with the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/), can help demystify cannabis for both patients and providers, such public-facing materials often lack the clinical nuance needed for medical decision-making. The [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) is indeed relevant to understanding [cannabis pharmacology](https://cedclinic.com/cannabis-tolerance-behavioral-models/), but isolated “facts” presented without discussion of dose-response relationships, individual variation in metabolism, drug interactions, or long-term safety data may oversimplify a complex pharmacology and inadvertently reinforce assumptions about [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) or efficacy. Healthcare providers should recognize that patient knowledge increasingly comes from diverse online sources, some of which may emphasize [cannabis benefits](https://cedclinic.com/cannabis-and-sexuality-benefits-intimacy/) while downplaying risks or acknowledging gaps in evidence. When patients reference such materials during clinical encounters, providers have an opportunity to contextualize this information within established evidence, discuss potential harms alongside mechanisms of action, and clarify what is known versus unknown about clinical

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%2010%20Facts%20you%20didn%27t%20know%20about%20THC%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D69907)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D69907)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%2010%20Facts%20you%20didn%27t%20know%20about%20THC%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D69907)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

Related Articles

- [The Entourage Effect: Why THC Percentage Isn’t Everything](https://cedclinic.com/the-entourage-effect-why-thc-percentage-isnt-everything/)

- [Hamilton Ends Its Dispensary Ban, but the Local Restrictions Still Matter](https://cedclinic.com/hamilton-ohio-dispensary-ban-what-changed/)

- [San Francisco Approves Cannabis Cafes, and the Public Health Questions Start Now](https://cedclinic.com/san-francisco-cannabis-cafe-vote-public-health/)

📰 Source: [https://www.youtube.com/playlist?list=PLEYV0oJUcGFU](https://www.youtube.com/playlist?list=PLEYV0oJUcGFU)

Further Reading
CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/)
Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/)
CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/)

[https://cedclinic.com/contact/](https://cedclinic.com/contact/)

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

[Leave a Message](https://cedclinic.com/contact/)
[Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
[Medical Consulting](https://cedclinic.com/book/)
[Cannabis Care](https://cedclinic.com/book/)

[https://cedclinic.com/contact/](https://cedclinic.com/contact/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
